The 5th annual Stem Cells & Regenerative Medicine Congress is where biotechs gather to explore the most promising trends in stem cell, cell and gene therapies.
Hear from cell therapy companies you’ve not heard from before, and get to know the top 20 next-to-launch biotechs.
This is your chance to hear from and network with industry pioneers!
- Mohammad Heidaran, Office of Cellular, Tissue and Gene Therapies, CBER, FDA
- Geert Cauwenbergh, President & CEO, RXi
- Robert Hariri, CEO, Cellular Therapeutics Division, Celgene
- Michael May, CEO, Centre for Commercialization of Regenerative Medicine
- And many more…